Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in NKTR — Nektar Therapeutics

CIK 923093 STAMFORD, CT

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$1,078,098 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Derivatives in NKTR

reported options exposure · as of Jun 30, 2026
CallValue
$2,345,616
CallShares
33,600
PutValue
$216,411
PutShares
3,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $216,411 3,100
2026-06-30 $2,345,616 33,600
2026-03-31 $1,078,098 14,984
2026-03-31 $294,995 4,100
2026-03-31 $410,115 5,700
2025-03-31 $38,816 57,083
2024-12-31 $53,087 57,083
2024-09-30 $74,207 57,083
2024-06-30 $70,782 57,083
2024-03-31 $53,087 57,083
2023-12-31 $31,966 57,083
2023-09-30 $34,249 57,083
2023-06-30 $33,108 57,083
2023-03-31 $39,958 57,083
2022-12-31 $600,769 265,827
2022-09-30 $854,601 267,063
2022-06-30 $1,838,394 483,788
2022-03-31 $2,547,788 472,688
2021-12-31 $1,759,893 130,266
2021-09-30 $1,744,149 97,113
2021-06-30 $3,052,060 177,859
2020-12-31 $295,817 17,401
2020-09-30 $1,675,125 100,972
2020-06-30 $2,206,846 95,287
2020-03-31 $709,965 39,774